Radioimmunodetection with (111)In–labeled Monoclonal Antibody Nd2 in Patients with Pancreatic Cancer

This report summarizes results from an initial clinical evaluation of radioimnumodetection (RAID) in patients with pancreatic cancer using murine monoclonal antibody Nd2, directed against mucins from pancreatic cancer.Nd2 (2 mg) was labeled with (111)ln (2 mCi) and injected into 19 patients suspecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Yong‐Suk, Sawada, Tetsuji, Kondo, Yasuyuki, Hirayama, Koji, Inui, Akimasa, Yamashita, Yoshito, Nakata, Bunzo, Okamura, Terue, Ochi, Hironobu, Ho, Jenny J. L., Kim, Young S., Sowa, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1997
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921428/
https://www.ncbi.nlm.nih.gov/pubmed/9197537
http://dx.doi.org/10.1111/j.1349-7006.1997.tb00400.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921428/
https://www.ncbi.nlm.nih.gov/pubmed/9197537
http://dx.doi.org/10.1111/j.1349-7006.1997.tb00400.x

Ejemplares similares